315 related articles for article (PubMed ID: 10933859)
1. Determination by electrospray mass spectrometry of the outersphere association constants of DNA/platinum complexes using 20-mer oligonucleotides and ([Pt(NH(3))(4)](2+), 2Cl(-)) or ([Pt(py)(4)](2+), 2Cl(-)).
Carte N; Legendre F; Leize E; Potier N; Reeder F; Chottard JC; Van Dorsselaer A
Anal Biochem; 2000 Aug; 284(1):77-86. PubMed ID: 10933859
[TBL] [Abstract][Full Text] [Related]
2. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
3. GA and AG sequences of DNA react with cisplatin at comparable rates.
Monjardet-Bas V; Bombard S; Chottard JC; Kozelka J
Chemistry; 2003 Oct; 9(19):4739-45. PubMed ID: 14566881
[TBL] [Abstract][Full Text] [Related]
4. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG
J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526
[TBL] [Abstract][Full Text] [Related]
5. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
6. GG sequence of DNA and the human telomeric sequence react with cis-diammine-diaquaplatinum at comparable rates.
Ourliac Garnier I; Bombard S
J Inorg Biochem; 2007 Mar; 101(3):514-24. PubMed ID: 17224184
[TBL] [Abstract][Full Text] [Related]
7. How strong can the bend be on a DNA helix from cisplatin? DFT and MP2 quantum chemical calculations of cisplatin-bridged DNA purine bases.
Burda JV; Leszczynski J
Inorg Chem; 2003 Nov; 42(22):7162-72. PubMed ID: 14577785
[TBL] [Abstract][Full Text] [Related]
8. Comparison between HPLC and capillary electrophoresis for the separation and identification of the platination products of oligonucleotides with cis-[Pt(NH3)2(H2O)2]2+ and [Pt(NH3)3(H2O)]2+.
Troujman H; Chottard JC
Anal Biochem; 1997 Oct; 252(1):177-85. PubMed ID: 9324957
[TBL] [Abstract][Full Text] [Related]
9. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
Deubel DV
J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
[TBL] [Abstract][Full Text] [Related]
10. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.
Saad JS; Benedetti M; Natile G; Marzilli LG
Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625
[TBL] [Abstract][Full Text] [Related]
11. Unrestrained 5 ns molecular dynamics simulation of a cisplatin-DNA 1,2-GG adduct provides a rationale for the NMR features and reveals increased conformational flexibility at the platinum binding site.
Elizondo-Riojas MA; Kozelka J
J Mol Biol; 2001 Dec; 314(5):1227-43. PubMed ID: 11743736
[TBL] [Abstract][Full Text] [Related]
12. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
Barry CG; Baruah H; Bierbach U
J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
[TBL] [Abstract][Full Text] [Related]
13. Tuning the DNA reactivity of cis-platinum: conjugation to a mismatch-specific metallointercalator.
Petitjean A; Barton JK
J Am Chem Soc; 2004 Nov; 126(45):14728-9. PubMed ID: 15535691
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
Boccarelli A; Coluccia M; Intini FP; Natile G; Locker D; Leng M
Anticancer Drug Des; 1999 Jun; 14(3):253-64. PubMed ID: 10500500
[TBL] [Abstract][Full Text] [Related]
15. Binding of DNA purine sites to dirhodium compounds probed by mass spectrometry.
Chifotides HT; Koomen JM; Kang M; Tichy SE; Dunbar KR; Russell DH
Inorg Chem; 2004 Oct; 43(20):6177-87. PubMed ID: 15446862
[TBL] [Abstract][Full Text] [Related]
16. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer.
McGowan G; Parsons S; Sadler PJ
Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542
[TBL] [Abstract][Full Text] [Related]
17. Duplex-promoted platination of adenine-N3 in the minor groove of DNA: challenging a longstanding bioinorganic paradigm.
Barry CG; Day CS; Bierbach U
J Am Chem Soc; 2005 Feb; 127(4):1160-9. PubMed ID: 15669855
[TBL] [Abstract][Full Text] [Related]
18. High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.
Egger AE; Hartinger CG; Ben Hamidane H; Tsybin YO; Keppler BK; Dyson PJ
Inorg Chem; 2008 Nov; 47(22):10626-33. PubMed ID: 18947179
[TBL] [Abstract][Full Text] [Related]
19. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
20. NMR and X-ray structural characterization of a cisplatin analogue able to slow down the Pt-N7 rotation of a coordinated guanine base by a billion-fold times: 2,2'-bipiperidine(dimethylmalonato)platinum(II) complex.
Intini FP; Cini R; Tamasi G; Hursthouse MB; Natile G
Inorg Chem; 2008 Jun; 47(11):4909-17. PubMed ID: 18447326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
